KK
INDV icon

KLP Kapitalforvaltning’s Indivior Pharmaceuticals INDV Stock Holding History

KLP Kapitalforvaltning’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
44,026
+1,400
+3% +$50.8K 0.01% 830
2026
Q1 		$1.3M Sell
42,626
-8,300
-16% -$274K 0.01% 904
2025
Q4 		$1.83M Sell
50,926
-500
-1% -$15.3K 0.01% 751
2025
Q3 		$1.24M Buy
+51,426
New +$1.08M ﹤0.01% 912

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's INDV Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Indivior Pharmaceuticals (INDV) stake by 3.3% in Q2 2026, buying an estimated $50.8K and bringing the position to 44,026 shares worth $1.81M. The position accounts for 0.01% of the portfolio, ranked #830.

KLP Kapitalforvaltning first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.83M in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • KLP Kapitalforvaltning held 44,026 shares of Indivior Pharmaceuticals worth $1.81M as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,400 Indivior Pharmaceuticals shares in Q2 2026, an estimated $50.8K.
  • Indivior Pharmaceuticals made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #830 holding.
  • KLP Kapitalforvaltning first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • KLP Kapitalforvaltning's Indivior Pharmaceuticals position peaked at $1.83M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.